PDFs by language
Our 24/7 cancer helpline provides support for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
At our National Cancer Information Center trained Cancer Information Specialists can answer questions 24 hours a day, every day of the year to empower you with accurate, up-to-date information to help you make educated health decisions. We connect patients, caregivers, and family members with valuable services and resources.
Or ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Treatment for testicular cancer is based mainly on the type and stage of the cancer. Among the different stages of germ cell tumors, pure seminomas tend to be treated one way, and non-seminomas and mixed germ cell tumors are treated another way.
In this stage, the cancer has not spread outside the testicle, and tumor marker levels (like HCG and AFP) are not elevated.
If CIS is diagnosed after surgery removes the testicle, no other treatment is needed. If CIS is found after a testicular biopsy (such as for fertility problems), the doctor may recommend that it not be treated right away. Instead, it may be watched closely with repeat physical exams, ultrasound of the testicle, and blood tests of tumor marker levels. Treatment may not be needed as long as there are no signs that the CIS is growing or turning into an invasive cancer. If CIS is treated, it's typically surgery (to remove the testicle) or radiation therapy to the testicle.
If tumor marker levels are high, the cancer isn't really stage 0 – even when only CIS is found in the testicle and there are no signs of cancer spread. In this case, the treatment used is for stage IS cancers. (See below.)
These cancers can be cured in nearly all patients. Surgery is done first to remove the testicle and spermatic cord (called a radical inguinal orchiectomy). After surgery, there are often several treatment choices:
Careful observation (surveillance): If the cancer has not spread beyond the testicle, the plan most experts prefer is close monitoring for up to 10 years. This means getting physical exams and blood tests every 3 to 6 months for the first year, and less often after that. Imaging tests (CT scans and sometimes chest x-rays) are done every 3 months for 6 months, and then once or twice a year. If these tests do not find any signs that cancer has spread beyond the testicle, no other treatment is needed. If the cancer has spread, treatments like radiation or chemo may be used. The cancer will come back in about 15% to 20% of patients, most often as spread to lymph nodes, but if it does, radiation or chemo can still usually cure the cancer.
Radiation therapy: Radiation aimed at para-aortic lymph nodes is another option. These nodes are in the back of the abdomen (belly), around the large blood vessel called the aorta. Because seminoma cells are very sensitive to radiation, low doses can be used. About 10 to 15 treatments are given over 2 to 3 weeks.
Chemotherapy: An option that works as well as radiation is 1 or 2 cycles of chemo with the drug carboplatin after surgery. Many experts prefer chemo over radiation because it seems to be easier to tolerate.
In this stage, one or more tumor marker levels is still high after the testicle containing the seminoma has been removed. This is very rare, and it can be treated with chemo.
Radiation: After surgery to remove the testicle (radical inguinal orchiectomy), one treatment option is radiation to the retroperitoneal lymph nodes. These are the lymph nodes at the back of the abdomen (belly). Usually stage II seminomas are given higher doses of radiation than stage I seminomas.
Chemotherapy: Another option is chemo, with either 4 cycles of EP (etoposide and cisplatin) or 3 cycles of BEP (bleomycin, etoposide, and cisplatin). The doctor will then watch closely (every 3 to 6 months) for any signs that the cancer has come back.
These seminomas have spread to cause larger lymph nodes or have spread to many different lymph nodes.
Chemotherapy: This is typically the preferred treatment. It is usually either 4 cycles of EP (etoposide and cisplatin) or 3 cycles of BEP (bleomycin, etoposide, and cisplatin).
Radiation: This may be an option instead of chemo if the lymph nodes aren't enlarged from cancer spread.
Treatment is typically chemotherapy with 4 cycles of EP (etoposide and cisplatin) or 3 or 4 cycles of BEP (bleomycin, etoposide, and cisplatin). Another option might be VIP (etoposide, ifosfamide, and cisplatin) for 4 cycles. Radiation therapy is generally not used for stage IIC seminoma.
Nearly all of these cancers can be cured, but the treatment is different from that of seminomas. As with seminomas, the initial treatment is surgery to remove the testicle and tumor (called radical inguinal orchiectomy). The other treatment choices will depend on the stage.
If your tumor marker levels (like AFP or HCG) are still high even after the cancer has been removed, but the CT scan doesn't show a tumor, chemo is typically recommended. This may be either 3 cycles of BEP (bleomycin, etoposide, and cisplatin) or 4 cycles of EP (etoposide and cisplatin).
Surgery is done first to remove the testicle and spermatic cord (called a radical inguinal orchiectomy). After surgery, treatment choices depend on the details of the cancer.
Treatment depends on tumor marker levels after surgery and the extent of spread to the retroperitoneal lymph nodes. These are the lymph nodes at the back of the abdomen (belly).
If tumor marker levels are normal, there are 2 main options:
If tumor markers are still higher than normal after the initial surgery, treatment is typically with chemo as listed above (EP or BEP)..
Treatment depends on tumor marker levels after surgery and the extent of spread to the lymph nodes at the back of the abdomen (belly). These are called the retroperitoneal lymph nodes.
If tumor marker levels are normal, the options are:
If tumor markers are still higher than normal after the initial surgery, treatment is typically with chemo as listed above (EP or BEP).
Even though stage III cancers have spread by the time they are found, most of them can still be cured.
Both stage III seminomas and non-seminomas are treated with radical inguinal orchiectomy, followed by chemo. Depending on the risk group the cancer falls into, this might be with:
If there's a high suspicion that the cancer might be a testicular choriocarcinoma, chemo may be started without a biopsy or surgery to remove the testicle.
If the cancer has spread to the brain, surgery (if there are only 1 or 2 tumors in the brain), radiation therapy aimed at the brain, or both may also be used. If the tumors in the brain are not bleeding or causing symptoms, some doctors may choose to start the chemo first.
Once chemo is complete, the doctor looks for any cancer that's left. If scans and tumor marker levels are normal, no further treatment may be needed.
Sometimes a few tumors might be left after treatment. These are most often in the lung or in the retroperitoneal lymph nodes. Further treatment at this point depends on the type of cancer:
If the cancer is resistant to chemo or has spread to many organs, the usual doses of chemo may not always be enough. The doctor might recommend high-dose chemo followed by a stem cell transplant. Enrolling in a clinical trial of a newer chemo regimen might be another good option.
If the cancer goes away with treatment and then comes back, it's said to have recurred or relapsed. If this happens, it’s usually within the first 2 years after treatment. In general, if the cancer recurs, it’s probably best to get a second opinion from a center with extensive experience in treating relapsed testicular cancer before starting treatment.
Treatment of recurrent germ cell tumors depends on the initial treatment and where the cancer recurs. Cancer that comes back in the retroperitoneal lymph nodes can be treated by surgery to remove the nodes (RPLND) if the recurrence is small and if the only surgical treatment given before was orchiectomy. Depending on the results of the surgery, chemo may be recommended as well.
If it looks as if cancer has recurred in a lot of the retroperitoneal lymph nodes or if the cancer has returned elsewhere, chemo is usually recommended. This may be followed by surgery.
If a man’s cancer recurs after chemo or if treatment is no longer working, he will be treated with different chemo, which typically includes ifosfamide, cisplatin, and either etoposide, paclitaxel, or vinblastine.
The treatment of testicular cancer that has come back after chemo is not always as effective as doctors would like, so some doctors may advise high-dose chemo followed by a stem cell transplant. This may be a better option for some men with recurrent disease, rather than standard chemo. Clinical trials of newer treatments may also be good options.
Typically, radical inguinal orchiectomy is the treatment for Sertoli cell and Leydig cell tumors. Radiation therapy and chemo generally don't work for these rare types of testicular tumors. If the doctor suspects the tumor has spread beyond the testicle, the retroperitoneal lymph nodes may be surgically removed.
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
Allen JC, Kirschner A, Scarpato KR, Morgans AK. Current management of refractory germ cell tumors and future directions. Curr Oncol Rep. 2017;19(2):8.
Chortis V, Johal NJ, Bancos I, et al. Mitotane treatment in patients with metastatic testicular Leydig cell tumor associated with severe androgen excess. Eur J Endocrinol. 2018;178(3):K21-K27.
Hamilton RJ. Active Surveillance for Stage I Testicular Cancer: A four-decade-old experiment proven correct. Eur Urol. 2018 Mar 15.
National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Testicular Cancer, Version 1.2019. Accessed at www.nccn.org/professionals/physician_gls/pdf/testicular.pdf on September 4, 2019.
Smith ZL, Werntz RP, Eggener SE. Testicular Cancer: Epidemiology, Diagnosis, and Management. Med Clin N Am. 2018;102:251-264.
Last Revised: September 4, 2019
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.